[Pharmacological agents for treatment of paraphilias and hypersexual disorders].
We review the indications, modes of action, effectiveness, side effects, legal and ethical aspects of pharmacological agents which reduce sexual desire. It needs to be emphasized that these agents - regardless of their indication - should never be used without concomitant psychotherapy. Nevertheless, in this review we focus on pharmacotherapy, because it can be an important part of the therapeutic procedure and appropriate knowledge is required. A part of the review pertains to the therapy of male adolescents.
Hebebrand
K
K
Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters, Philipps-Universität, Marburg.
Hebebrand
J
J
Remschmidt
H
H
D000293:Adolescent; D000726:Androgen Antagonists / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*
D000726:Androgen Antagonists; D011619:Psychotropic Drugs; D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D017258:Medroxyprogesterone Acetate